We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MVBF icon
2201
MVB Financial
MVBF
$399M
$157K ﹤0.01%
3,791
– –
BBSI icon
2202
Barrett Business Services
BBSI
$770M
$157K ﹤0.01%
9,116
– –
IBRX icon
2203
ImmunityBio
IBRX
$8.18B
$157K ﹤0.01%
25,881
+9,230
+55% +$69.3K
EQBK icon
2204
Equity Bancshares
EQBK
$1.07B
$157K ﹤0.01%
4,632
– –
TCMD icon
2205
Tactile Systems Technology
TCMD
$549M
$157K ﹤0.01%
8,238
– –
CRGY icon
2206
Crescent Energy
CRGY
$3.94B
$157K ﹤0.01%
+12,363
New +$171K
ORMP icon
2207
Oramed Pharmaceuticals
ORMP
$182M
$156K ﹤0.01%
10,953
– –
RBCAA icon
2208
Republic Bancorp
RBCAA
$1.91B
$156K ﹤0.01%
3,075
– –
CRIS icon
2209
Curis
CRIS
$3.74M
$156K ﹤0.01%
82
+23
+39% +$54.7K
HY icon
2210
Hyster-Yale Materials Handling
HY
$624M
$155K ﹤0.01%
3,777
– –
DICE
2211
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$154K ﹤0.01%
+6,094
New +$179K
KLRS
2212
Kalaris Therapeutics
KLRS
$93.1M
$154K ﹤0.01%
518
– –
IAS
2213
DELISTED
Integral Ad Science
IAS
$154K ﹤0.01%
6,925
– –
RYTM icon
2214
Rhythm Pharmaceuticals
RYTM
$8.05B
$153K ﹤0.01%
15,372
– –
BHB icon
2215
Bar Harbor Bankshares
BHB
$684M
$153K ﹤0.01%
5,292
– –
CNXN icon
2216
PC Connection
CNXN
$2.05B
$153K ﹤0.01%
3,547
– –
GTHX
2217
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$153K ﹤0.01%
14,959
+5,019
+50% +$64K
IPI icon
2218
Intrepid Potash
IPI
$491M
$153K ﹤0.01%
3,574
– –
PHAT icon
2219
Phathom Pharmaceuticals
PHAT
$748M
$153K ﹤0.01%
7,762
– –
RYZ
2220
Ryerson Holding Corp
RYZ
$1.5B
$152K ﹤0.01%
5,848
– –
CCBG icon
2221
Capital City Bank Group
CCBG
$898M
$152K ﹤0.01%
5,769
– –
RLMD icon
2222
Relmada Therapeutics
RLMD
$501M
$152K ﹤0.01%
6,754
– –
FOR icon
2223
Forestar Group
FOR
$1.5B
$152K ﹤0.01%
6,983
– –
MCFT icon
2224
MasterCraft Boat Holdings
MCFT
$600M
$152K ﹤0.01%
5,356
– –
QUOT
2225
DELISTED
Quotient Technology Inc
QUOT
$152K ﹤0.01%
20,448
-11,327
-36% -$77.1K
87 88
89
90 91

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.